[Multiple enlarged metabolically active lymph nodes in 18F-FDG PET/CT after anti-CTLA-4 antibody therapy in metastatic melanoma - disease progression or immunologically induced side effect?]

Rofo. 2015 Nov;187(11):1036-7. doi: 10.1055/s-0034-1399672. Epub 2015 Jun 10.
[Article in German]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • CTLA-4 Antigen / antagonists & inhibitors*
  • Colon / diagnostic imaging
  • Diagnosis, Differential
  • Disease Progression*
  • Energy Metabolism / physiology*
  • Fluorodeoxyglucose F18*
  • Follow-Up Studies
  • Humans
  • Ipilimumab
  • Lymph Nodes / diagnostic imaging*
  • Lymphatic Metastasis / diagnostic imaging*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Melanoma / secondary*
  • Multimodal Imaging / methods*
  • Neoplasm Staging
  • Nose Neoplasms / drug therapy*
  • Nose Neoplasms / pathology
  • Positron-Emission Tomography / methods*
  • Tomography, X-Ray Computed / methods*

Substances

  • Antibodies, Monoclonal
  • CTLA-4 Antigen
  • Ipilimumab
  • Fluorodeoxyglucose F18